Angela Variola

1.4k total citations
32 papers, 355 citations indexed

About

Angela Variola is a scholar working on Genetics, Epidemiology and Rheumatology. According to data from OpenAlex, Angela Variola has authored 32 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Genetics, 16 papers in Epidemiology and 8 papers in Rheumatology. Recurrent topics in Angela Variola's work include Inflammatory Bowel Disease (16 papers), Microscopic Colitis (8 papers) and Liver Disease Diagnosis and Treatment (7 papers). Angela Variola is often cited by papers focused on Inflammatory Bowel Disease (16 papers), Microscopic Colitis (8 papers) and Liver Disease Diagnosis and Treatment (7 papers). Angela Variola collaborates with scholars based in Italy, United Kingdom and United States. Angela Variola's co-authors include Annarosa Floreani, E. Rosa Rizzotto, I. Carderi, Vincenzo Baldo, Andrea Geccherle, D. Marchesoni, Giorgio Soardo, Delia M. Paternoster, Walter Esposito and G. Mazzella and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Annals of the Rheumatic Diseases.

In The Last Decade

Angela Variola

26 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Angela Variola Italy	10	152	142	123	115	80	32	355
Vinod S. Hegade United Kingdom	13	286 1.9×	318 2.2×	411 3.3×	242 2.1×	63 0.8×	32	607
I Janczewska Sweden	12	143 0.9×	148 1.0×	112 0.9×	32 0.3×	83 1.0×	20	369
M Huorka Slovakia	11	194 1.3×	141 1.0×	32 0.3×	90 0.8×	170 2.1×	34	433
G. Manzionna Italy	10	236 1.6×	231 1.6×	70 0.6×	18 0.2×	268 3.4×	16	561
B.-G. Ericzon Sweden	13	124 0.8×	167 1.2×	124 1.0×	108 0.9×	19 0.2×	27	488
Endrit Shahini Italy	14	232 1.5×	135 1.0×	160 1.3×	81 0.7×	52 0.7×	53	521
EF Stange Germany	12	131 0.9×	148 1.0×	35 0.3×	94 0.8×	134 1.7×	34	368
Kengo Sasaki Japan	15	78 0.5×	357 2.5×	265 2.2×	77 0.7×	23 0.3×	55	529
L Mieles United States	15	121 0.8×	320 2.3×	213 1.7×	53 0.5×	53 0.7×	22	586
Hassan Ghoz United States	8	76 0.5×	149 1.0×	57 0.5×	45 0.4×	28 0.3×	47	269

Countries citing papers authored by Angela Variola

Since Specialization

Citations

This map shows the geographic impact of Angela Variola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela Variola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela Variola more than expected).

Fields of papers citing papers by Angela Variola

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela Variola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela Variola. The network helps show where Angela Variola may publish in the future.

Co-authorship network of co-authors of Angela Variola

This figure shows the co-authorship network connecting the top 25 collaborators of Angela Variola. A scholar is included among the top collaborators of Angela Variola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela Variola. Angela Variola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bertani, Lorenzo, Davide Giuseppe Ribaldone, Fabrizio Bossa, et al.. (2025). When to Switch to Subcutaneous Infliximab? The RE-WATCH Multicenter Study. Inflammatory Bowel Diseases. 31(12). 3363–3369.

Guadagni, I., et al.. (2025). Obesity and Chronic Inflammation: Implications for Rheumatoid Arthritis, Spondyloarthritis, and Ulcerative Colitis. Immunity Inflammation and Disease. 13(1). e70080–e70080. 7 indexed citations

Vernero, Marta, Cristina Bezzio, Davide Giuseppe Ribaldone, et al.. (2024). Immune-Mediated Inflammatory Diseases Awareness and Management among Physicians Treating Patients with Inflammatory Bowel Disease: An IG-IBD Survey. Journal of Clinical Medicine. 13(7). 1857–1857. 1 indexed citations

Giovannini, Ivan, Annarita Tullio, Ilaria Tinazzi, et al.. (2024). Arthralgia and Extraintestinal Manifestations in Crohn’s Disease Elevate the Risk of IBD-Related Arthritis over Sacroiliitis. Rheumatology and Therapy. 12(1). 99–108.

Nardone, Olga Maria, Dario Bruzzese, Mariangela Allocca, et al.. (2024). Italian validation of the IBD-disk tool for the assessment of disability in inflammatory bowel diseases: A cross-sectional multicenter study. Digestive and Liver Disease. 57(3). 753–761.

Todeschini, Alessandra, et al.. (2023). P422 Transition from intravenous to subcutaneous infliximab and vedolizumab: adherence, satisfaction and safety profile in a cohort of patients with Inflammatory Bowel Disease. Journal of Crohn s and Colitis. 17(Supplement_1). i551–i552. 1 indexed citations

Cereser, Lorenzo, Ivan Giovannini, Carmelo Cicciò, et al.. (2022). Asymptomatic sacroiliitis detected by magnetic resonance enterography in patients with Crohn's disease: prevalence, association with clinical data, and reliability among radiologists in a multicenter study of adult and pediatric population. Clinical Rheumatology. 41(8). 2499–2511. 5 indexed citations

Ruscio, Mirko Di, Dora Buonfrate, Federico Gobbi, et al.. (2021). A Seroprevalence Study of Anti-SARS-CoV-2 Antibodies in Patients with Inflammatory Bowel Disease during the Second Wave of the COVID-19 Pandemic in Italy. Medicina. 57(10). 1048–1048. 3 indexed citations

Variola, Angela, Maria Elisabetta Zanolin, Pierluigi Macchioni, et al.. (2020). The IBIS-Q [IBd Identification of Spondyloarthritis Questionnaire]: A Novel Tool to Detect Both Axial and Peripheral Arthritis in Inflammatory Bowel Disease Patients. Journal of Crohn s and Colitis. 14(12). 1680–1686. 22 indexed citations

10.

Ruscio, Mirko Di, Angela Variola, Filippo Vernia, et al.. (2020). Role of Ulcerative Colitis Endoscopic Index of Severity (UCEIS) versus Mayo Endoscopic Subscore (MES) in Predicting Patients′ Response to Biological Therapy and the Need for Colectomy. Digestion. 102(4). 534–545. 22 indexed citations

11.

Variola, Angela, Mirko Di Ruscio, Giuliano Barugola, et al.. (2019). P125 Role of UCEIS vs. MES in predicting patients unresponsive to biological therapy and need for surgery: a retrospective single-centre analysis. Journal of Crohn s and Colitis. 13(Supplement_1). S150–S151.

12.

Biscaglia, Giuseppe, Edoardo Savarino, Angela Variola, et al.. (2018). P613 Predictors of treatment persistence in ulcerative colitis patients treated with golimumab: A multicentre cohort study. Journal of Crohn s and Colitis. 12(supplement_1). S419–S419. 1 indexed citations

13.

Floreani, Annarosa, D. Caroli, Angela Variola, et al.. (2010). A 35-year follow-up of a large cohort of patients with primary biliary cirrhosis seen at a single centre. Liver International. 31(3). 361–368. 51 indexed citations

14.

Floreani, Annarosa, Roberta Lazzari, Veronica Macchi, et al.. (2009). Hepatic expression of endocannabinoid receptors and their novel polymorphisms in primary biliary cirrhosis. Journal of Gastroenterology. 45(1). 68–76. 24 indexed citations

15.

Floreani, Annarosa, et al.. (2008). A Study of the Mu Opioid Receptor Gene Polymorphism A118G in Patients with Primary Biliary Cirrhosis with and without Pruritus. Acta Dermato Venereologica. 88(4). 323–326. 10 indexed citations

16.

Floreani, Annarosa, Angela Variola, Grazia Anna Niro, et al.. (2008). Plasma Adiponectin Levels in Primary Biliary Cirrhosis: A Novel Perspective for Link Between Hypercholesterolemia and Protection Against Atherosclerosis. The American Journal of Gastroenterology. 103(8). 1959–1965. 40 indexed citations

17.

Floreani, Annarosa, I. Carderi, Delia M. Paternoster, et al.. (2007). Hepatobiliary phospholipid transporter ABCB4, MDR3 gene variants in a large cohort of Italian women with intrahepatic cholestasis of pregnancy. Digestive and Liver Disease. 40(5). 366–370. 56 indexed citations

18.

Floreani, Annarosa, et al.. (2006). A novel multidrug-resistance protein 2 gene mutation identifies a subgroup of patients with primary biliary cirrhosis and pruritus. Hepatology. 43(5). 1152–1154. 12 indexed citations

19.

Floreani, Annarosa, I. Carderi, Delia M. Paternoster, et al.. (2006). Intrahepatic cholestasis of pregnancy: three novel MDR3 gene mutations. Alimentary Pharmacology & Therapeutics. 23(11). 1649–1653. 52 indexed citations

20.

Carderi, I., Nora V. Bergasa, Angela Variola, et al.. (2006). A novel multidrug-resistance protein 2 gene mutation identifies a subgroup of patients with primary biliary cirrhosis and pruritus. Digestive and Liver Disease. 38. S34–S34. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact